| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19832f7a81121085475b833c44c73b24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc66489654f219f236714f5090c19fc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c59f40e7211546c33e0fdfc636f8b80e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71321ff1a1eeda093fcc3972306efe21 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-101666
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70564 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-553 |
| filingDate |
2009-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_328a8b12d2ab03cddcc5b1c21d28a53e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b983aa519e8c92693f5c761bc325e504
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fe72eff2059ddf58a43645c39a0e30f |
| publicationDate |
2013-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8546092-B2 |
| titleOfInvention |
One step nanosensor for single and multidrug resistance in acute coronary syndrome (ACS) |
| abstract |
An embodiment relates to a method of detecting a drug resistance in a patient comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Another embodiment relates to a method of monitoring a thrombotic risk factor in a subject in a general population comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Yet another embodiment relates to a kit comprising nanoparticles, a fluorescence dye tagged antibody and optionally a buffer, wherein the kit is configured to detect a drug resistance in a patient or a likelihood of the thrombotic risk factor in a subject in general population. |
| priorityDate |
2009-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |